MoneyWorks4Me

Alkem Laboratories informs about press release

22 Sep 2025 Evaluate
Alkem Laboratories has informed that the company launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer. A press release in this regard is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1845.20
Dr. Reddys Labs. 1165.85
Cipla 1355.00
Lupin 2091.05
Zydus Lifesciences 1118.25
View more..